IM
ImageneBio Inc (IMA)
NASDAQ·Healthcare·Biotechnology
$4.11
—
Mkt Cap $66.20M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$1.33
Range $1.33 – $1.33
Implied Upside
-67.6%
Consensus $1.33 vs current $4.11
NASDAQ·Healthcare·Biotechnology
$4.11
—
Mkt Cap $66.20M
No recent rating data.
Price Target (2 analysts)
$1.33
Range $1.33 – $1.33
-67.6%
Consensus $1.33 vs current $4.11